• Users Online: 322
  • Print this page
  • Email this page
Year : 2021  |  Volume : 4  |  Issue : 1  |  Page : 30-32

Late effect of chemotherapy for osteosarcoma on kidney function

Department of Pediatrics, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan

Correspondence Address:
Takuji Enya
Department of Pediatrics, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/AJPN.AJPN_29_20

Rights and Permissions

With improvement in the outcomes of chemotherapy, the management of late effects of chemotherapy is an increasingly important concern in patients with osteosarcoma. However, the risk factors for late effects on kidney function are not clear. We report seven cases of osteosarcoma, including three patients with severe or recurrent drug-induced acute kidney injury, who were diagnosed with tubulointerstitial nephritis after the treatment of osteosarcoma. Although late renal effects are considered to be dose-dependent, they are not invariable with the same protocol. The severity and frequency of acute kidney injury following chemotherapy might have influenced the occurrence of renal late effects.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded90    
    Comments [Add]    

Recommend this journal